- ·The complete investor list: 30 names
- ·Watch J-Pharma (TKS: 520A): the Monday email on marks, rounds and moves
J-Pharma (TKS: 520A) funding history
No funding rounds for J-Pharma (TKS: 520A) are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
J-Pharma (TKS: 520A) valuation
J-Pharma (TKS: 520A) is now publicly traded; this page covers its private-market history, where its last recorded valuation was $99.4 million (Mar 2026). Secondary trades, fund marks and rounds below are the private-market record; the listed share price is not tracked here.
How J-Pharma (TKS: 520A)'s valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For J-Pharma (TKS: 520A), too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked about J-Pharma (TKS: 520A)
- What is J-Pharma (TKS: 520A) worth?
- J-Pharma (TKS: 520A)'s last known valuation is $99.4M.
- How much has J-Pharma (TKS: 520A) raised?
- J-Pharma (TKS: 520A) has raised $83.1M in total funding across its recorded rounds.